VIAD PHARMA ApS Financials, key figures and credit report
Gross profit 1 031.0 kDKK FY 2025 -38.9% vs 2024
EBIT 271.2 kDKK FY 2025 -70.9% vs 2024
Net debt - 311.1 kDKK FY 2025 +66.7% vs 2024
Quick ratio 1.1 FY 2025 -0.6 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 048.04 | 1 006.60 | 1 257.51 | 1 686.09 | 1 031.00 |
| Employee benefit expenses | - 688.70 | - 688.34 | - 693.91 | - 755.46 | - 759.83 |
| EBIT | 359.33 | 318.26 | 563.61 | 930.63 | 271.17 |
| Other financial expenses | -36.59 | -76.20 | -80.09 | -41.80 | -54.08 |
| Pre-tax profit | 322.74 | 242.06 | 483.52 | 888.84 | 217.09 |
| Income taxes | -72.31 | -53.77 | - 107.27 | - 196.68 | -49.06 |
| Net earnings | 250.43 | 188.29 | 376.25 | 692.16 | 168.03 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 67.46 | 77.79 | 213.94 | 191.44 | 69.66 |
| Current other receivables | 0.10 | 0.10 | |||
| Short term receivables total | 67.46 | 77.79 | 214.04 | 191.54 | 69.66 |
| Cash and bank deposits | 1 920.78 | 2 210.38 | 2 699.93 | 1 675.12 | 1 999.00 |
| Cash and cash equivalents | 1 920.78 | 2 210.38 | 2 699.93 | 1 675.12 | 1 999.00 |
| Balance sheet total (assets) | 1 988.24 | 2 288.17 | 2 913.97 | 1 866.66 | 2 068.66 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 250.43 | 188.29 | 376.25 | 692.16 | 168.03 |
| Retained earnings | - 232.06 | - 169.92 | - 357.88 | - 673.79 | - 149.66 |
| Profit of the financial year | 250.43 | 188.29 | 376.25 | 692.16 | 168.03 |
| Shareholders equity total | 318.79 | 256.65 | 444.62 | 760.52 | 236.40 |
| Non-current liabilities total | |||||
| Current trade creditors | 11.54 | 8.60 | 11.90 | 11.46 | 11.26 |
| Current owed to group member | 1 492.22 | 1 881.11 | 2 214.81 | 739.84 | 1 687.86 |
| Short-term deferred tax liabilities | 196.68 | 49.06 | |||
| Other non-interest bearing current liabilities | 165.69 | 141.81 | 242.64 | 158.16 | 84.08 |
| Current liabilities total | 1 669.45 | 2 031.52 | 2 469.36 | 1 106.13 | 1 832.26 |
| Balance sheet total (liabilities) | 1 988.24 | 2 288.17 | 2 913.97 | 1 866.66 | 2 068.66 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated